Correlation Between Cannara Biotech and European Residential

Can any of the company-specific risk be diversified away by investing in both Cannara Biotech and European Residential at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cannara Biotech and European Residential into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cannara Biotech and European Residential Real, you can compare the effects of market volatilities on Cannara Biotech and European Residential and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cannara Biotech with a short position of European Residential. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cannara Biotech and European Residential.

Diversification Opportunities for Cannara Biotech and European Residential

0.48

Correlation Coefficient

Cannara Biotech  European Residential

Very weak diversification

The 3 months correlation between Cannara and European is 0.48. Overlapping area represents the amount of risk that can be diversified away by holding Cannara Biotech and European Residential Real in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on European Residential Real and Cannara Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cannara Biotech are associated (or correlated) with European Residential. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of European Residential Real has no effect on the direction of Cannara Biotech i.e., Cannara Biotech and European Residential go up and down completely randomly.

Pair Corralation between Cannara Biotech and European Residential

Assuming the 90 days trading horizon Cannara Biotech is expected to generate 2.53 times more return on investment than European Residential. However, Cannara Biotech is 2.53 times more volatile than European Residential Real. It trades about 0.05 of its potential returns per unit of risk. European Residential Real is currently generating about 0.11 per unit of risk. If you would invest  66.00  in Cannara Biotech on September 25, 2024 and sell it today you would earn a total of  6.00  from holding Cannara Biotech or generate 9.09% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Cannara Biotech  vs.  European Residential Real

Cannara Biotech

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Cannara Biotech are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Cannara Biotech showed solid returns over the last few months and may actually be approaching a breakup point.

European Residential Real

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in European Residential Real are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak technical and fundamental indicators, European Residential sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Cannara Biotech and European Residential

The main advantage of trading using opposite Cannara Biotech and European Residential positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cannara Biotech position performs unexpectedly, European Residential can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in European Residential will offset losses from the drop in European Residential's long position.

The idea behind Cannara Biotech and European Residential Real pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.